4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-004100
Director sold 2,409 shares at $2.00 ($4,818)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Neil Harris Director | 2022-11-16 | Sale | −2,409 | $2.00 | $4,818 | 10,000 | D: show line 1 in the form |
| Open-market sales · 2,409 sh · avg $2.00 · $4,818 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Neil Harris Director | 2022-03-07 | Grant or award · Option to Purchase American Depositary Shares | +6,820 | 6,820 | D: show line 2 in the form | |||||
| Cohen Neil Harris Director | 2021-04-19 | Grant or award · Option to Purchase American Depositary Shares | +11,884 | 11,884 | D: show line 3 in the form | |||||
| Cohen Neil Harris Director | 2021-03-16 | Grant or award · Option to Purchase American Depositary Shares | +688 | 688 | D: show line 4 in the form |
Loading xslF345X03/zk2228788.xml…